Finerenone and Troleandomycin: Interaction Details

Brand names
Finerenone
Kerendia
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Troleandomycin

We don't have a drug information page for Troleandomycin because it is no longer sold in the US: the FDA lists every approved version as discontinued. Have a question about Troleandomycin? Ask a pharmacist, free →

What Happens When You Take Finerenone With Troleandomycin

What can happen when they are taken together (rated Contraindicated)

Increased finerenone exposure and an increased risk of finerenone-related adverse effects

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Finerenone is a , and giving it together with a strong CYP3A4 is , because the inhibitor raises finerenone exposure and could heighten the risk of finerenone adverse reactions. When finerenone was co-administered with itraconazole, a strong CYP3A4 inhibitor, the of finerenone rose by more than 400%.1

The Finerenone and Troleandomycin Interaction, Explained

Finerenone (Kerendia) is a kidney and heart protective medicine that your body breaks down mainly using an enzyme called . Troleandomycin is an antibiotic that blocks this enzyme, so finerenone can build up in your body. Too much finerenone can raise potassium to unsafe levels, lower blood pressure, and put extra stress on the kidneys.

This pairing is listed as , which means it should not be combined. The evidence for troleandomycin itself is theoretical, but a similar strong blocker raised finerenone levels more than fivefold. Please do not stop or change anything on your own. Talk with your pharmacist or doctor, who can help choose a safer plan for you.

Mechanism: Troleandomycin is a strong . Finerenone is a CYP3A4 , so reduces its and increases systemic exposure.

  • Magnitude: Itraconazole, a strong CYP3A4 inhibitor, increased finerenone by more than 400%. Data for troleandomycin are extrapolated (theoretical).
  • Risk: Increased finerenone adverse effects, notably , , and function decline.
  • Onset: Unspecified.
  • Severity: (class-based labeling for strong CYP3A4 ).
  • Management: Avoid . Consider a non-CYP3A4-inhibiting alternative for the infection or an alternative therapy plan, and monitor potassium and renal function if exposure occurs.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Finerenone and Troleandomycin Interact

The likely mechanism

of -mediated of finerenone

In short: Troleandomycin slows CYP3A4, an enzyme that breaks down finerenone, so finerenone can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Finerenone and Troleandomycin Interaction

The documented guidance is that these two medicines should not be used together. Your care team can usually avoid the problem by choosing a different antibiotic or by reviewing your finerenone plan.

  • Tell your pharmacist and prescriber about every medicine you take, including antibiotics from other clinics.
  • Do not stop or change either medicine on your own. Ask your care team first.
  • If you have already taken both, contact your pharmacist or doctor promptly. They may monitor you more closely.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Finerenone or Troleandomycin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: KERENDIA oral tablets, finerenone oral tablets

    When finerenone, a , was given together with itraconazole, a strong CYP3A4 , the of finerenone rose by more than 400%.1

Finerenone and Troleandomycin: Common Questions

How serious is the Finerenone and Troleandomycin interaction?

It is rated . These should generally not be used together.

How is the Finerenone and Troleandomycin interaction managed?

The documented guidance is that these two medicines should not be used together. Your care team can usually avoid the problem by choosing a different antibiotic or by reviewing your finerenone plan. Tell your pharmacist and prescriber about every medicine you take, including antibiotics from other clinics. Do not stop or change either medicine on your own. Ask your care team first. If you have alr… Management is individual — always follow your own care team's guidance.

Does taking Finerenone and Troleandomycin at different times of day help?

No. Taking them at different times of day does not prevent this one. Troleandomycin slows , an enzyme that breaks down finerenone, so finerenone can build up in the body. That change lasts while troleandomycin is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Finerenone and Troleandomycin Interaction

Ask in your own words about taking Finerenone and Troleandomycin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: KERENDIA(R) oral tablets, finerenone oral tablets. Bayer HealthCare Pharmaceuticals Inc (per FDA), Whippany, NJ, 2025. DailyMed
Was this write-up helpful?

Other Serious Interactions of Finerenone and Troleandomycin

Also serious with Troleandomycin

Also serious with Finerenone

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Troleandomycin

With Finerenone

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.